**Star News, on December 23, 2023, Caitong Pure Bond (000497) issued an announcement to hire Wu Wei as the ** manager, and the date of appointment will be from December 23, 2023, and the ** manager of Caitong Pure Bond (000497) after the change is Zhang Wanyu and Wu Wei. As of December 22, 2023, the net value of Caitong's pure bond bonds is 12354, compared with the previous day**006%, in the past year**573%。
Mr. Wu Wei: China, Master of Finance, Shanghai University of Finance and Economics. He has successively served as a researcher at Shenwan Hongyuan Research Institute, a researcher at Industrial Economic Research and Consulting Co., Ltd., and a researcher at CIC Morgan Management. In May 2022, he joined Caitong ** Management *** and served as the assistant manager of the fixed income investment department, and is now the ** manager of the fixed income investment department. On February 10, 2023, he was appointed as the manager of Caitong Convertible Bond Investment.
The public offerings it has managed are as follows:
Review of the performance of heavy stocks: The Caitong convertible bond A under its management was transferred to Wanneng Power in the second quarter of 2023, and the average price of the quarter was 2152, after holding for 1 consecutive quarter, it will be transferred out in the third quarter of 2023, and the average price of the current quarter will be 2351, with an estimated yield of 925% (the estimated yield is calculated based on the average quarterly price of the post-compounded transfer-in and transfer-out).
The above content is compiled by **Star based on public information, generated by algorithms, and has nothing to do with the position of this site. **Star strives but does not guarantee the accuracy, completeness, validity, timeliness of all or part of the content of the information (including but not limited to text, **audio, data and charts), if there is any problem, please contact us. This article is a compilation of data and does not constitute any investment advice for you, investment is risky, please make a cautious decision.